Efficacy study of CT 7001

Trial Profile

Efficacy study of CT 7001

Phase of Trial: Phase II

Latest Information Update: 05 Dec 2017

At a glance

  • Drugs CT-7001 (Primary)
  • Indications Acute myeloid leukaemia; Breast cancer; Cancer; Small cell lung cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 05 Dec 2017 New trial record
    • 30 Nov 2017 According to a Carrick Therapeutics media release,this trial is planned in 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top